Lifeward (NASDAQ:LFWD) vs. Envoy Medical (NASDAQ:COCH) Head to Head Review

Envoy Medical (NASDAQ:COCH – Get Free Report) and Lifeward (NASDAQ:LFWD – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, analyst recommendations and profitability.

Analyst Ratings

This is a summary of recent ratings for Envoy Medical and Lifeward, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envoy Medical 1 1 2 0 2.25
Lifeward 1 1 2 0 2.25

Envoy Medical currently has a consensus price target of $21.00, indicating a potential upside of 210.19%. Lifeward has a consensus price target of $8.00, indicating a potential upside of 107.47%. Given Envoy Medical’s higher probable upside, analysts plainly believe Envoy Medical is more favorable than Lifeward.

Institutional and Insider Ownership

8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 26.8% of Lifeward shares are held by institutional investors. 7.2% of Envoy Medical shares are held by insiders. Comparatively, 1.1% of Lifeward shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Envoy Medical and Lifeward”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Envoy Medical $240,000.00 218.33 -$23.76 million ($4.60) -1.47
Lifeward $22.03 million 0.50 -$19.91 million ($16.82) -0.23

Lifeward has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Envoy Medical and Lifeward’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Envoy Medical -9,026.41% N/A -112.19%
Lifeward -155.37% -281.70% -83.03%

Volatility & Risk

Envoy Medical has a beta of 2.03, suggesting that its share price is 103% more volatile than the S&P 500. Comparatively, Lifeward has a beta of 0.55, suggesting that its share price is 45% less volatile than the S&P 500.

About Envoy Medical

(Get Free Report)

Envoy Medical is a medical technology company focused on developing implantable hearing devices. Based in White Bear Lake, Minnesota, the company was founded in 1995 and specializes in technologies intended to help people with hearing loss. Its product portfolio includes the Esteem Active Middle Ear Implant, an FDA-approved fully implanted hearing device for adults with moderate to severe sensorineural hearing loss. The company is also developing Acclaim, a fully implanted cochlear implant designed for people with severe to profound hearing loss.

About Lifeward

(Get Free Report)

Lifeward Ltd. develops and markets medical devices for mobility, rehabilitation and physical therapy. Its products include wearable robotic exoskeletons designed to help people with mobility impairments stand and walk, as well as systems used in rehabilitation settings. The company’s offerings include the ReWalk exoskeleton for people with spinal cord injuries and the ReStore exo-suit for gait training after stroke. Lifeward also sells AlterG anti-gravity treadmills, which use differential air pressure to reduce the user’s effective body weight during walking or running exercises.

Receive News & Ratings for Envoy Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envoy Medical and related companies with MarketBeat.com's FREE daily email newsletter.